An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study

Veure altres versions (2)

Objective: To evaluate the performance of the QRISK2 score for predicting 10-year cardiovascular disease in an independent UK cohort of patients from general practice records and to compare it with the NICE version of the Framingham equation and QRISK1. Design: Prospective cohort study to validate a...

Descripció completa

Dades bibliogràfiques
Autors principals:	Collins, G, Altman, D
Format:	Journal article
Idioma:	English
Publicat:	2010

Ítems similars

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
per: Collins, G, et al.
Publicat: (2010)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
per: Collins, G, et al.
Publicat: (2010)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.
per: Collins, G, et al.
Publicat: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: A prospective open cohort study
per: Collins, G, et al.
Publicat: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study
per: Collins, G, et al.
Publicat: (2009)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
per: Collins, G, et al.
Publicat: (2012)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
per: Collins, G, et al.
Publicat: (2012)

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
per: Parsons, RE, et al.
Publicat: (2023)

QRISK validation and evaluation Authors' reply
per: Collins, G, et al.
Publicat: (2009)

QRISK2-2011 predicted cardiovascular disease in adult general practice patients
per: Collins, G, et al.
Publicat: (2012)

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
per: Hippisley-Cox, J, et al.
Publicat: (2017)

QRISK validation and evaluation. QRISK may be less useful.
per: Liew, S, et al.
Publicat: (2009)

QRISK validation and evaluation: QRISK may be less useful
per: Su, M, et al.
Publicat: (2009)

Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.
per: Collins, G, et al.
Publicat: (2011)

Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.
per: Collins, G, et al.
Publicat: (2011)

UPDATED VERSION OF QRISK2 Authors' reply to Bird
per: Collins, G, et al.
Publicat: (2012)

Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UK.
per: Collins, G, et al.
Publicat: (2012)

Predicting the adverse risk of statin treatment: An independent and external validation of Qstatin risk scores in the UK
per: Collins, G, et al.
Publicat: (2012)

Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study
per: Shona Livingstone, MSc, et al.
Publicat: (2021-06-01)

Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
per: Manpreet Singh, et al.
Publicat: (2022-07-01)

Chronic renal disease is not chronic kidney disease: implications for use of the QRISK and Joint British Societies risk scores
per: Stevens, S, et al.
Publicat: (2015)

QRISK 3® and ASCVD Risk Calculator in Patients with Diabetes and Their Correlation with Coronary Artery Calcium Scores
per: Subramanian Kannan, et al.
Publicat: (2024-12-01)

Assessment of QRISK3 Score in Normoglycaemic, Prediabetic and Diabetic Subjects: An Observational Study
per: Aayushee Rao, et al.
Publicat: (2023-07-01)

Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus
per: Xiaodie Mu, et al.
Publicat: (2022-11-01)

Cardiovascular disease risk communication in NHS Health Checks using QRISK®2 and JBS3 risk calculators: the RICO qualitative and quantitative study
per: Christopher J Gidlow, et al.
Publicat: (2021-08-01)

Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(®) (Pancreas).
per: Collins, G, et al.
Publicat: (2013)

Identifying women with undetected ovarian cancer: independent and external validation of QCancer(®) (Ovarian) prediction model.
per: Collins, G, et al.
Publicat: (2013)

Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study
per: Shona J. Livingstone, et al.
Publicat: (2022-05-01)

Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?
per: Tjeerd-Pieter van Staa, et al.
Publicat: (2014-01-01)

Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction model.
per: Collins, G, et al.
Publicat: (2013)

Ten-year cardiovascular disease risk and related factors in lifetime marijuana use with comorbid methamphetamine-associated psychotic disorder: a QRISK®3 study
per: Dilek Örüm, et al.
Publicat: (2024-08-01)

Lipidomic risk scores are independent of polygenic risk scores and can predict incidence of diabetes and cardiovascular disease in a large population cohort.
per: Chris Lauber, et al.
Publicat: (2022-03-01)

Quantitative examination of video-recorded NHS Health Checks: comparison of the use of QRISK2 versus JBS3 cardiovascular risk calculators
per: Christopher J Gidlow, et al.
Publicat: (2020-09-01)

Predictive role of novel echocardiographic parameter aortic velocity propagation, QRISK3 and Framingham risk score for presence and severity of CAD in Asian patients
per: Pooja Vyas, et al.
Publicat: (2022-09-01)

External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis.
per: Eric H Sasso, et al.
Publicat: (2024-01-01)

Correction: Performance of risk prediction scores for cardiovascular mortality in older persons: External validation of the SCORE OP and appraisal.
per: Marco Piccininni, et al.
Publicat: (2020-01-01)

External validation of QDSCORE(®) for predicting the 10-year risk of developing Type 2 diabetes.
per: Collins, G, et al.
Publicat: (2011)

External validation of the QLifetime cardiovascular risk prediction tool: population cohort study
per: Shona Livingstone, et al.
Publicat: (2023-04-01)

External validation of the ACC/AHA ASCVD risk score in a Colombian population cohort
per: Carlos Daniel Rodríguez-Ariza, et al.
Publicat: (2023-04-01)

Cardiovascular risk scoring for the prevention of cardiovascular disease in low-resource settings
per: Collins, DRJ
Publicat: (2017)